Fludeoxyglucose F 18 Injection Market Revenue was valued at USD 1.5 Billion in 2024 and is estimated to reach USD 2.8 Billion by 2033, growing at a CAGR of 7.5% from 2026 to 2033.
In 2022, the global Fludeoxyglucose F 18 Injection market was valued at approximately USD 3.5 billion and is projected to reach around USD 5.6 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.1% from 2022 to 2030. This growth is primarily driven by the increasing prevalence of cancer and neurological disorders, along with the rising demand for diagnostic imaging technologies in healthcare facilities. Fludeoxyglucose F 18 (FDG) is extensively used in positron emission tomography (PET) imaging to assess metabolic activities in various conditions, including cancer, heart disease, and neurological disorders. The expansion of healthcare infrastructure and the growing adoption of PET scanners globally further contribute to market growth. Regionally, North America dominated the nuclear medicine market, which includes Fludeoxyglucose F 18 Injection, with a market share of 51.79% in 2023. The U.S. market, in particular, is projected to grow significantly, reaching an estimated value of USD 21.85 billion by 2032, driven by strong innovation and adoption of various therapeutic and diagnostic radiopharmaceuticals. Europe follows as another significant market due to well established healthcare systems and government initiatives promoting cancer and chronic disease diagnosis. The Asia Pacific region is anticipated to exhibit the fastest growth, attributed to rising healthcare expenditure, growing awareness among patients, and increasing investments in healthcare infrastructure.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=565274&utm_source=Google_Site&utm_medium=226
Â
Isologic
Siemens(PETNet)
Yantai Dongcheng Biochemicals Co.
Ltd.
Hta Co.
Ltd
Guangdong Cyclotron Medical Science Co.
Ltd
HUAYI Technology
Shanghai Atom Kexing Pharmaceutical Co.
Ltd.
China Isotope & Radiation Corporation
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=565274&utm_source=Google_Site&utm_medium=226
Growing demand for below applications around the world has had a direct impact on the growth of the Global Fludeoxyglucose F 18 Injection Market
Fludeoxyglucose F-18 Injection (Single-Dose)
Fludeoxyglucose F-18 Injection (Multi-Dose)
Fludeoxyglucose F-18 Injection (Pre-filled Syringes)
Oncology Diagnostics
Cardiology Imaging
Neurology Imaging
Infectious Disease Imaging
Metabolic Disorders Imaging
Hospitals
Diagnostic Imaging Centers
Research Institutions
Pharmaceutical Companies
Direct Sales
Distributors
Online Pharmacies
Refrigerated Storage
Room Temperature Storage
Controlled Environment Storage
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/fludeoxyglucose-f-18-injection-market/
1. Introduction of the Global Fludeoxyglucose F 18 Injection Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Fludeoxyglucose F 18 Injection Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Fludeoxyglucose F 18 Injection Market, By Type
6. Global Fludeoxyglucose F 18 Injection Market, By Application
7. Global Fludeoxyglucose F 18 Injection Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Fludeoxyglucose F 18 Injection Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/